Schlusskurs
Andere Börsenplätze
|
||
- BDT | - |
Kurzporträt
Umsatz nach Geschäftsbereich
BDT in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
100,0
%
| 34 669 | 100,0 % | 39 267 | 100,0 % | +13,26 % |
Umsatz je Region
BDT in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Bangladesh
100,0
%
| 34 669 | 100,0 % | 39 267 | 100,0 % | +13,26 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Director of Finance/CFO | 61 | 01.01.90 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 01.03.05 | |
Director/Board Member | - | - | |
Mehboobul Haque
PRN | Corporate Officer/Principal | - | - |
Human Resources Officer | - | - | |
Shawkat Haider
PRN | Corporate Officer/Principal | - | - |
Roksana Hassan
AUD | Comptroller/Controller/Auditor | - | - |
Shamim Momtaz
PRN | Corporate Officer/Principal | - | 01.01.07 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Founder | - | 01.01.76 | |
Founder | - | 01.01.76 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 01.01.85 |
Director/Board Member | - | 01.01.91 | |
Director/Board Member | - | 01.01.93 | |
Director/Board Member | - | - | |
Director/Board Member | - | 30.07.20 | |
Director/Board Member | 64 | 30.11.20 | |
Reem Shamsuddoha
BRD | Director/Board Member | 36 | 30.11.20 |
Director/Board Member | 64 | 18.01.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 446 112 089 | 342 099 318 ( 76,68 %) | 0 | 76,68 % |
Unternehmenskontakt
Beximco Pharmaceuticals Ltd.
19 Dhanmondi R/A Road No. 7
1205, Dhaka
+880 2 5861 1001
http://www.beximcopharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+31,52 % | 662 Mrd. | |
+21,96 % | 546 Mrd. | |
-5,21 % | 359 Mrd. | |
+17,02 % | 323 Mrd. | |
+5,01 % | 289 Mrd. | |
+13,68 % | 234 Mrd. | |
+3,81 % | 198 Mrd. | |
-10,63 % | 194 Mrd. | |
+3,98 % | 167 Mrd. |
- Börse
- Aktien
- BXPHARMA Aktie
- Aktie
- Unternehmen Beximco Pharmaceuticals Limited